UnitedHealth Group Incorporated (NYSE:UNH) Shares Acquired by Bay Rivers Group

Bay Rivers Group boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNHFree Report) by 3.7% during the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 5,755 shares of the healthcare conglomerate’s stock after buying an additional 204 shares during the period. UnitedHealth Group accounts for approximately 1.9% of Bay Rivers Group’s holdings, making the stock its 24th largest holding. Bay Rivers Group’s holdings in UnitedHealth Group were worth $3,030,000 as of its most recent SEC filing.

A number of other institutional investors have also recently bought and sold shares of UNH. Keebeck Wealth Management LLC lifted its holdings in shares of UnitedHealth Group by 11.6% during the 2nd quarter. Keebeck Wealth Management LLC now owns 10,788 shares of the healthcare conglomerate’s stock valued at $5,185,000 after acquiring an additional 1,122 shares in the last quarter. Ascension Capital Advisors Inc. purchased a new stake in shares of UnitedHealth Group during the third quarter valued at approximately $216,000. Physician Wealth Advisors Inc. purchased a new position in shares of UnitedHealth Group in the third quarter valued at $207,000. Bartlett & Co. LLC raised its position in shares of UnitedHealth Group by 5.7% in the 3rd quarter. Bartlett & Co. LLC now owns 164,353 shares of the healthcare conglomerate’s stock valued at $82,865,000 after purchasing an additional 8,873 shares in the last quarter. Finally, Great Valley Advisor Group Inc. raised its stake in shares of UnitedHealth Group by 5.8% in the 3rd quarter. Great Valley Advisor Group Inc. now owns 34,297 shares of the healthcare conglomerate’s stock valued at $17,292,000 after purchasing an additional 1,884 shares in the last quarter. 85.69% of the stock is currently owned by hedge funds and other institutional investors.

Insider Buying and Selling

In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction dated Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the transaction, the chief accounting officer now directly owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. In other news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The shares were sold at an average price of $525.79, for a total transaction of $451,127.82. Following the completion of the sale, the chief accounting officer now owns 32,289 shares in the company, valued at approximately $16,977,233.31. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares of the company’s stock, valued at $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is owned by corporate insiders.

UnitedHealth Group Stock Performance

Shares of UNH stock traded down $2.54 during trading hours on Thursday, reaching $491.69. 3,663,591 shares of the company’s stock were exchanged, compared to its average volume of 4,191,339. UnitedHealth Group Incorporated has a fifty-two week low of $445.68 and a fifty-two week high of $554.70. The business has a fifty day moving average price of $506.58 and a 200-day moving average price of $518.24. The stock has a market capitalization of $453.30 billion, a P/E ratio of 20.62, a P/E/G ratio of 1.34 and a beta of 0.54. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.62.

UnitedHealth Group (NYSE:UNHGet Free Report) last posted its quarterly earnings results on Friday, January 12th. The healthcare conglomerate reported $6.16 EPS for the quarter, beating the consensus estimate of $5.98 by $0.18. The firm had revenue of $94.43 billion during the quarter, compared to analysts’ expectations of $92.13 billion. UnitedHealth Group had a return on equity of 26.39% and a net margin of 6.02%. The company’s revenue for the quarter was up 14.1% on a year-over-year basis. During the same quarter in the prior year, the firm posted $5.34 EPS. Analysts predict that UnitedHealth Group Incorporated will post 27.79 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Tuesday, March 19th. Shareholders of record on Monday, March 11th were paid a dividend of $1.88 per share. This represents a $7.52 dividend on an annualized basis and a yield of 1.53%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is 31.54%.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on UNH. Stephens reaffirmed an “overweight” rating and set a $605.00 price objective on shares of UnitedHealth Group in a research report on Thursday, February 8th. Erste Group Bank reiterated a “hold” rating on shares of UnitedHealth Group in a research report on Wednesday, March 13th. Truist Financial reiterated a “buy” rating and issued a $610.00 target price on shares of UnitedHealth Group in a research report on Thursday, November 30th. Piper Sandler decreased their price target on UnitedHealth Group from $584.00 to $581.00 and set an “overweight” rating for the company in a research note on Wednesday, January 17th. Finally, HSBC reaffirmed a “reduce” rating and set a $480.00 target price (down from $550.00) on shares of UnitedHealth Group in a report on Monday, December 18th. One analyst has rated the stock with a sell rating, two have given a hold rating, fifteen have assigned a buy rating and one has issued a strong buy rating to the stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of “Moderate Buy” and an average target price of $579.33.

Get Our Latest Analysis on UNH

About UnitedHealth Group

(Free Report)

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

Further Reading

Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNHFree Report).

Institutional Ownership by Quarter for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.